All stock lists
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
Healthcare · Diagnostics & Research
$1.66+$0.07 (+4.40%)
Insider Score
––Not scored
IMDX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
IMDX Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $559.00 K | $239.00 K | $32.00 K | $1.14 M | $260.00 K | — |
| Revenue Growth (YoY) | 115.00 % | — | — | — | — | — |
| Cost of Revenue | $139.00 K | $82.00 K | $17.00 K | $643.00 K | $121.00 K | — |
| Gross Profit | $420.00 K | $157.00 K | $15.00 K | $496.00 K | $139.00 K | — |
| SG&A Expense | $4.14 M | $4.50 M | $5.14 M | $4.38 M | $3.70 M | — |
| R&D Expense | $3.79 M | $4.49 M | $4.95 M | $5.83 M | $3.88 M | — |
| Operating Expenses | $8.19 M | $9.24 M | $10.35 M | $10.45 M | $7.81 M | — |
| Operating Income | -$7.76 M | -$9.09 M | -$10.33 M | -$9.95 M | -$7.67 M | — |
| Pretax Income | -$3.58 M | -$11.26 M | -$4.29 M | -$22.95 M | -$10.85 M | — |
| Tax Provision | $0.00 | — | $0.00 | — | $0.00 | $0.00 |
| Net Income | -$3.58 M | -$11.26 M | -$4.29 M | -$22.95 M | -$10.85 M | — |
| EPS (Basic) | -$0.10 | -$0.31 | -$0.12 | -$0.72 | -$0.34 | — |
| EPS (Diluted) | -$0.10 | -$0.31 | -$0.12 | -$0.72 | -$0.34 | — |
| Shares Outstanding | 36.86 M | 36.75 M | 34.52 M | 32.06 M | 32.03 M | — |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
